Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qurs Mulayyan is a classical Unani tablet formulation designed to support digestive health and provide relief from constipation. Developed and marketed by Dawakhana Tibbiya (along with other traditional Unani manufacturers like Hamdard and Dehlvi Naturals), this herbal remedy acts as a gentle laxative and purgative. It is formulated with a blend of traditional herbs, including *Terminalia chebula* (Halela), *Terminalia belerica* (Bahera), *Emblica officinalis* (Amla), *Ipomoea turpethum* (Nisoth), and *Rheum emodi* (Rewandchini). Qurs Mulayyan works by softening stools, promoting regular bowel movements, and relieving stomach heaviness and bloating without causing dependency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qurs Mulayyan.